← Back to headlines
Wegovy and Ozempic owner dealt blow as next-gen weight-loss drug is labelled ‘obsolete’
Novo Nordisk’s shares fall sharply after testing of CagriSema falls short of investors’ expectations
23 Feb, 14:26 — 23 Feb, 14:26
ℹOnly 1 source covers this story
Related Stories
Understanding Emotional Intelligence and Its Importance for Success
9m ago
Christina Applegate Opens Up About Her Battle with Multiple Sclerosis
13m ago
Indian Comedian Tanmay Bhat Discusses Weight Loss Journey and GLP-1 Drugs
14m ago
Relatives Allege Misdiagnosis in Death of 46-Year-Old Sailor in Skyros
16m ago